产品中心 药物靶点和Fc受体 药物靶点

所有图片(1/1)

Properdin His Tag Protein, Human

Properdin,Complement factor P,CFP,PFC

价格 1,400.00 供应商现货 : 3-5个工作日
货号 UA011168
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 物种

    Human
  • 分子别名

    Properdin; Complement factor P; CFP; PFC
  • Accession

    P27918
  • 表达序列

    Asp28-Leu469 with His Tag at the C-terminus

  • 表达宿主

    HEK293
  • 分子量

    43-55 kDa (Reducing)
  • 纯度

    >95% by SDS-PAGE & RP-HPLC
  • 内毒素含量

    <0.1EU/μg
  • 标记

    Unconjugated
  • 标签

    His Tag
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, PH7.4,5% trehalose

  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.

  • 文献引用

    1.Pillemer, L. et al. (1954) Science 120:279.
    2.Kemper, C. et al. (2010) Annu. Rev. Immunol. 28:131.

背景介绍
  • Properdin, also known as Complement factor P (CFP) or PFC, is a glycoprotein of approximately 53 kDa that serves as a positive regulator of the alternative pathway of the complement system. It enhances the activity of this pathway by binding to and stabilizing the C3 and C5 convertase complexes, thereby significantly extending their half-lives. Properdin is primarily produced by various subsets of leukocytes and circulates as cyclic oligomers of monomeric subunits.
    Properdin augments the formation of platelet/granulocyte aggregates (PGA) through increased production of C5a. This process is strictly regulated by Factor H. Inhibition of Properdin function holds therapeutic potential for limiting thromboinflammation, particularly in diseases characterized by increased PGA formation. Deficiency in Properdin increases susceptibility to infections, such as meningococcal disease.

  • 电泳

    • 1μg (R: reducing condition, N: non-reducing condition).

评论(0)